http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#Head http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#assertion http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#provenance http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#pubinfo http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#assertion http://purl.obolibrary.org/obo/DOID_8567 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_8567 http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB08870 http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association http://www.w3.org/2000/01/rdf-schema#label adcetris is a cd3 directed antibody drug conjugate indicated for treatment of adult patients with previously untreated stage iii or iv classical hodgkin lymphoma chl in combination with doxorubicin vinblastine and dacarbazine 1 1 classical hodgkin lymphoma chl at high risk of relapse or progression as post autologous hematopoietic stem cell transplantation auto hsct consolidation 1 2 classical hodgkin lymphoma chl after failure of auto hsct or after failure of at least two prior multi agent chemotherapy regimens in patients who are not auto hsct candidates 1 3 previously untreated systemic anaplastic large cell lymphoma salcl or other cd3 expressing peripheral t cell lymphomas ptcl including angioimmunoblastic t cell lymphoma and ptcl not otherwise specified in combination with cyclophosphamide doxorubicin and prednisone 1 4 systemic anaplastic large cell lymphoma salcl after failure of at least one prior multi agent chemotherapy regimen 1 5 primary cutaneous anaplastic large cell lymphoma pcalcl or cd3 expressing mycosis fungoides mf who have received prior systemic therapy 1 6 adcetris is indicated for the treatment of adult patients with previously untreated stage iii or iv chl in combination with doxorubicin vinblastine and dacarbazine adcetris is indicated for the treatment of adult patients with chl at high risk of relapse or progression as post autologous hematopoietic stem cell transplantation auto hsct consolidation adcetris is indicated for the treatment of adult patients with chl after failure of auto hsct or after failure of at least two prior multi agent chemotherapy regimens in patients who are not auto hsct candidates adcetris is indicated for the treatment of adult patients with previously untreated salcl or other cd3 expressing ptcl including angioimmunoblastic t cell lymphoma and ptcl not otherwise specified in combination with cyclophosphamide doxorubicin and prednisone adcetris is indicated for the treatment of adult patients with salcl after failure of at least one prior multi agent chemotherapy regimen adcetris is indicated for the treatment of adult patients with pcalcl or cd3 expressing mf who have received prior systemic therapy http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB08870 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#provenance http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#pubinfo http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#sig http://purl.org/nanopub/x/hasSignature WImQ4v4cYgPava3wn/U00F+zkAZScY+5lpGGJP3feXQHEujl7OPjX54IBfnHV7meMVssTRLnI4JdqJOmqu45qFk90HwvAduYkX6Na85pfd8B1QgNYb4lgFUazz6b2SUy88Oec1jPIPlAs4ncgtVMZweu2ly6TQVdllaXYCniZ2Y= http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8 http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8 http://purl.org/dc/terms/created 2021-07-03T14:58:06.103+02:00 http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAEXlhtka0sWqDGxkfaPZ5kozaD96IfOpkMMKI4aH7Os8 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs